White House to deploy surge teams to COVID-19 hotspots; J&J reports vaccine elicits antibodies against Delta variant
The White House plans to deploy COVID-19 surge response teams to help communities experiencing or at risk for hotspots due to the Delta variant and low vaccination with vaccination, testing, contact tracing, therapeutics and staffing, White House COVID-19 Response Coordinator Jeff Zients announced yesterday.
“These are dedicated teams working with communities at higher risk for or already experiencing outbreaks due to the spread of the Delta variant and their low vaccination rate,” Zients said.
In other news, Johnson and Johnson yesterday said its single-shot COVID-19 vaccine demonstrated strong neutralizing antibody activity against the Delta variant in blood samples from eight participants in its phase 3 clinical trial of the vaccine
Related News Articles
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…